Ablynx NV

Technologiepark 21 Zwijnaarde
Gent, 9052
Belgium View Map >>

P: +32 9 262 00 00
F: +32 9 262 00 01
www.ablynx.com
Description
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Ablynx is dedicated to creating new medicines which will make a real difference t... more

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Contact People at this company

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Contact People at this company
Revenue
84434
Employees
344

Industries

Biotechnology, Drug Manufacturing & Research, Business Services

Similar Companies

MediGene AG, MorphoSys AG, PAION AG, Trigen Ltd

Stock Market

EUR: ABLX

SIC Codes

2834, 8731

NAICS Codes

325412, 541711

Recently updated profiles at this company (304 contacts available)

Nancy Dhont
Junior Purchaser
Vicky Goderis
Junior Clinical Data Manager
Hilde De Winter
Senior Med. Director
Ortwin Van de Vyver
Associate Scientist - Pharmacology PD-
Ine Elebaut
Clinical Trial Lead
Sabine Demeester
Clinical Program Manager
Cindy Catry
Senior Research Associate
An Van der Vorst
Clinical Program Manager
Thea Eggermont
Research Associate
Stefanie Deronne
Legal Manager
City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory